Xtl Biopharmaceuticals (XTLB) Price to Book (2011 - 2024)
Xtl Biopharmaceuticals' (XTLB) Price to Book stood at 251.39 in the quarter ended Dec 31, 2024, up 1.4% from 247.91 a year earlier and up 9.9% from the prior quarter.
Powered by 
Analysis
Xtl Biopharmaceuticals (XTLB) Price to Book (2011 - 2024) Analysis & Trends
Starting with the quarter ended Dec 31, 2011, Xtl Biopharmaceuticals' Price to Book history includes 53 quarters.
- Across earlier years, Price to Book came in at 247.91 in the year ended Dec 31, 2023 (+50.4%), 164.88 in the year ended Dec 31, 2022 (-41.7%), 283.03 in the year ended Dec 31, 2021 (-34.4%) and 431.35 in the year ended Dec 31, 2020 (+298.9%).
- Quarterly Price to Book has ranged from 90.48 in the quarter ended Mar 31, 2020 to 731.48 in the quarter ended Sep 30, 2021 over the past five years.
- On a year-over-year basis, Price to Book has increased for eight consecutive quarters, with growth averaging 62.7% over the last eight quarters.
- Peak year-over-year performance for Price to Book in the last five years was growth of 351.3% in the quarter ended Sep 30, 2021, against a decline of 82.6% in the quarter ended Sep 30, 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at 228.75 (quarter ended Sep 30, 2024), 592.98 (quarter ended Jun 30, 2024) and 566.06 (quarter ended Mar 31, 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Xtl Biopharmaceuticals | 2.27 Bn | 2.27 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 251.39 |
| Sep 30, 2024 | 228.75 |
| Jun 30, 2024 | 592.98 |
| Mar 31, 2024 | 566.06 |
| Dec 31, 2023 | 247.91 |
| Sep 30, 2023 | 196.09 |
| Jun 30, 2023 | 200.48 |
| Mar 31, 2023 | 231.69 |
| Dec 31, 2022 | 164.88 |
| Sep 30, 2022 | 127.50 |
| Jun 30, 2022 | 148.89 |
| Mar 31, 2022 | 220.98 |
| Dec 31, 2021 | 283.03 |
| Sep 30, 2021 | 731.48 |
| Jun 30, 2021 | 625.13 |
| Mar 31, 2021 | 392.10 |
| Dec 31, 2020 | 431.35 |
| Sep 30, 2020 | 162.08 |
| Jun 30, 2020 | 146.13 |
| Mar 31, 2020 | 90.48 |
API Access
Xtl Biopharmaceuticals Price to Book API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-book&ticker=XTLB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-book", "ticker": "XTLB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-book&ticker=XTLB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();